China expected to be the only country among G20 to post growth in 2020 – leading macroeconomic influencers
China’s economy was earlier predicted to contract but new estimates show that the country may post growth during the year.…
17 Sep 2020
Takeda bets on Engitix’s ECM drug discovery platform for liver fibrosis
London-headquartered Engitix is partnering with pharma giant Takeda to discover and develop novel therapies for advanced fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH). The pair will leverage Engitix’s proprietary extracellular…
17 Sep 2020
World economy may contract at a lower rate owing to faster recovery in certain regions, according to leading macroeconomic influencers
The world economy was estimated to contract by 6% in 2020 in June but the figures have been revised to 4.5%. Strong recovery particularly in the US and China have…
16 Sep 2020
Q&A: Breaking new ground in pharma packaging with Honeywell
These are interesting times for pharma packaging company Honeywell. Known for Aclar – a moisture barrier film for oral solid dose packaging – the company recently broke new ground with…
16 Sep 2020
World Trade Organisation states that US sanctions against China violate trade laws, according to leading macroeconomic influencers
The US had imposed specific sanctions on China in 2018 citing state-sanctioned technology theft and other unfair practices. A report from the World Trade Organisation (WTO) has noted that the…
15 Sep 2020
Spotlight on Heart Failure: AZ and WHF partner to raise awareness
Heart failure is a cardiovascular disease (CVD) characterised by the heart’s inability to pump blood around the body properly. Affecting around 64 million people worldwide, this CVD places a huge…
15 Sep 2020
Biggest influencers in digital pharma in Q2 2020: The top individuals to follow
GlobalData research has found the top digital pharma influencers based on their performance and engagement online. Using research from GlobalData’s Influencer platform, Pharmaceutical Technology has named ten of the most…